The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References

Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below. 

5 – Ehsan Shokri-Kojori et al., Proceedings of the National Academy of Sciences of the United States of America 115, no. 17, 4483–88, April 2018

β-Amyloid Accumulation in the Human Brain After One Night of Sleep Deprivation

6 – Hedok Lee et al., The Journal of Neuroscience 35, no. 31, 11034–44, August 2015

The Effect of Body Posture on Brain Glymphatic Transport

7 – Ram A. Sharma et al., American Journal of Respiratory and Critical Care Medicine 197, no. 7, 933–43, April 2018

Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study

8 – National Institute of Environmental Health Sciences, last modified October 12, 2018

Flame Retardants

9 – David Nutt, Sue Wilson, and Louise Paterson, Dialogues in Clinical Neuroscience 10, no. 3, 329–36, September 2008

Sleep Disorders as Core Symptoms of Depression

10 – Dale E. Bredesen, Aging 8, no. 2, 304–13, February 2016

Inhalational Alzheimer’s Disease: An Unrecognized – and Treatable – Epidemic

11 – Juhee Haam and Jerrel L. Yakel, Journal of Neurochemistry 142, supplement 2, 111–21, 2017

Cholinergic Modulation of the Hippocampal Region and Memory Function

12 – Sophie Billioti de Gage et al., BMJ 2014, 349, September 2014

Benzodiazepine Use and Risk of Alzheimer’s Disease: Case-Control Study

13 – Simon Crowe and Elizabeth K. Stranks, Archives of Neuropsychology 33, no. 7, 901–11, December 2017

The Residual Medium and Long-Term Cognitive Effects of Benzodiazepine Use: An Updated Meta-Analysis

14 – Talita H. Ferreira-Vieira et al., Current Neuropharmacology 14, no. 1, 101–15, January 2016

Alzheimer’s Disease: Targeting the Cholinergic System